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Background: Subclinical hypothyroidism (SH) is a relatively common condition characterized by a mild persistent
thyroid failure. The management of children with SH is still a controversial issue and the decision to treat with
L-thyroxine represents a clinical dilemma. Thyroid hormone and TSH play an important role in skeletal growth and
bone mineral homeostasis.
Aim: To evaluate whether untreated idiopathic SH may affect bone health in childhood and to compare two
different diagnostic tools such as dual-energy X-ray densitometry (DXA) and quantitative ultrasound (QUS).
Patients and Methods: Twenty-five children and adolescents (11 males) aged 9.8 ± 3.5 years (range 4.2-18.7) with
untreated idiopathic SH were enrolled in the study. SH was diagnosed on the basis of normal FT4 levels with TSH
concentrations between 4.2 and 10 mU/l. Children have been followed for 3.3 ± 0.3 years from the time of SH
diagnosis. Twenty-five healthy children, age- and sex-matched, were enrolled as controls. Patients and controls
underwent DXA to evaluate lumbar spine bone mineral density (BMD) and QUS at proximal phalanges of the
non-dominant hand to assess bone quality, measured as amplitude-dependent speed of sound (Ad-SoS) and bone
transmission time (BTT).
Results: Mean BMD Z-score was −0.4 ± 1.36 in patients and −0.2 ± 1.2 in controls. Mean Ad-SoS Z-score was
0.01 ± 1.0 in patients and 0.1 ± 1.2 in controls and mean BTT Z-score was −0.03 ± 0.8 and 0.04 ± 1.1 respectively.
All values were within the normal range, both in patients and in controls. There were no statistically significant
differences between the two groups.
Conclusion: Bone health, evaluated by lumbar spine DXA and phalangeal QUS, is not impaired in our children,
despite long-term duration of idiopathic SH. Data about bone status provided by QUS are comparable to those
provided by DXA. Therefore, QUS may represent a good, cheaper and safe screening test for bone evaluation in
children with SH.
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Subclinical hypothyroidism (SH) is defined by the serum
TSH concentration above the upper limit of the refer-
ence range and serum free T4 concentration within the
reference range [1]. The prevalence is comprised be-
tween 4 and 20% of the adult population [2] and about
1.7 % in US children [3]. Although in adults mild clinical
signs or symptoms of hypothyroidism have been
reported in some cases, there is no full consensus about* Correspondence: salerno@unina.it
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reproduction in any medium, provided the orthe management of these subjects. Moreover, there is no
clear evidence of beneficial effect of L-thyroxine treat-
ment [4]. The management of children with SH is an
even more controversial issue. Recent data indicated that
idiopathic SH is a benign condition that in the majority
of cases does not progress into overt hypothyroidism
[5,6] and does not affect linear growth [7,8].
Thyroid hormone plays a critical role in postnatal skel-
etal development and in bone remodeling, influencing
osteoclast-induced bone resorption and osteoblast-
induced bone formation [9]. Hyperthyroidism increases
bone turnover and reduces the remodeling cycle timel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in overt and subclinical hyperthyroid patients [10-16].
As for the effect of hypothyroidism on bone, hystomor-
phometry data indicated that hypothyroidism signifi-
cantly prolongs the bone remodeling cycle resulting in a
reduced bone turnover and a gain in bone mass and
mineralization with consequent significantly greater
thickness in cortical bone [17]. In keeping with this data,
several studies have reported on an increased BMD in
adults with high or high-normal TSH, along with a posi-
tive correlation between BMD and TSH levels [18-20].
Furthermore, higher TSH levels were reported to be
protective against fractures [14]. Conversely, other stud-
ies on large adult population documented an increased
risk of fractures in adults with overt hypothyroidism
[21,22]. Current data from in vitro studies suggest that
TSH, through its receptor, has a direct effect on both
components of skeletal remodeling, osteoblastic bone
formation and osteoclastic bone resorption [23]. The
TSH receptor (TSHR) is a member of the seven trans-
membrane G-protein-coupled receptor family that also
includes the calcitonin and parathyroid hormone (PTH)
receptors, both regulators of bone turnover [24]. TSHR
knockout mice have severe osteoporosis. Heterozygous
TSHR+/− mice, despite normal T4 levels have significant
decrease in bone density. This finding suggests that also
a mild increase in TSH levels may influence bone me-
tabolism, particularly in non-autoimmune subclinical
hypothyroidism that may also be related to inactivating
mutation of TSHR. Studies on bone health in untreated
SH in childhood and adolescence are lacking. The most
important factor in the prevention of osteoporosis is the
attainment of an optimal peak bone mass, which is
mainly reached during late adolescent and early adult-
hood [25]. Therefore, measurement of bone mineral sta-
tus in childhood and adolescence may help identifying
subjects, who may be exposed to an increased risk of
osteoporosis later in adulthood.
Aim of this study was to evaluate whether untreated
SH may affect bone health assessed by two different
diagnostic tools such as dual-energy X-ray densitometry
(DXA) and quantitative ultrasound (QUS) in childhood.
Patients and methods
Patients
The study population consisted of 25 Caucasian children
(11 males), aged 9.8 ± 3.5 years (range 4.2-18.7) with un-
treated idiopathic SH. The diagnosis of idiopathic SH was
made on the basis of the following criteria: serum TSH
concentration between 4.5 mU/l and the conventional limit
of 10 mU/l with a serum free thyroxine (FT4) concentra-
tion within the reference range, along with the absence of
anti-thyroglobulin (Tg-Ab) and anti-thyroperoxidase anti-
bodies (TPO-Ab), normal echogenicity of the parenchymaon thyroid ultrasound and adequate urinary iodine excre-
tion. The criteria for enrollment also included the persist-
ence of a similar biochemical pattern of SH for at least 2
years prior to entering into the study and the absence of
palpable goiter or symptoms related to hypothyroidism.
In 13/25 SH children, thyroid function measurement
had been made for short stature (5 cases), obesity (1 case)
or familial history of thyroid diseases (7 cases). In the
remaining 12 cases, TSH measurement had been per-
formed as part of a check-up. From the first finding of SH
until the time of this study, all children were periodically
followed at our center. At enrollment in the study, the
duration of SH was 4.6 ± 2.8 (range 2.0-13.3) years. Six/25
subjects were pubertal. None of them was ever been trea-
ted with L-thyroxine. Twenty-five healthy euthyroid chil-
dren (14 males), matched for age, sex, and pubertal status,
who had undergone a check-up including also TSH meas-
urement participated in the study as controls.
Study protocol
At the entry into the study, all subjects underwent to clin-
ical examination, anthropometric measurements, determin-
ation of urinary iodine, fasting blood sample for calcium
(Ca), phosphorus (P), alkaline phosphates (ALP), parathy-
roid hormone (PTH), TSH, FT4, thyroglobuline (Tg), Tg-
Ab, TPO-Ab, insulin-like growth factor 1 (IGF1), bone age
(BA) assessment and bone status evaluation. Bone matur-
ation was evaluated using the Greulich and Pyle method
and was expressed as BA/chronological age (CA) ratio.
Moreover, all participants answered questionnaires on life-
style and health related topics including questions on phys-
ical activity, smoking habits, intake of calcium, former or
current diseases and use of medications.
The study protocol was approved by the Local Ethical
Committee and written informed consent to participate
into the study was obtained from the all subjects’ par-
ents when the chronological age was lower than 18 and
directly from each older subject.
Anthropometric data
Standing height was measured using a mechanical stadi-
ometer to the nearest 0.1 cm and body weight was mea-
sured with a mechanical balance to the nearest 0.1 kg.
The body mass index (BMI) was calculated as weight/
height2. Parental height was measured and target height
(TH) was calculated according to Tanner et al. [26].
Height, TH and BMI were also expressed as Z-score,
adjusted for age and gender in accordance with Italian
standards [27].
Laboratory data
A venous blood sample was drawn from all participants
at 8.00 in the morning after a 12-hour fast. TSH, FT4,
Tg, Tg-Ab, TPO-Ab and PTH serum concentrations
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assay (ECLIA) using a commercial kit (Elecsys ecobas
e. Roche Diagnostics) (reference ranges: TSH, 0.3–4.2
mU/l; FT4, 0.9–1.7 ng/dl; Tg, 0–50 ng/ml; Tg-Ab, 0–115
mIU/l; TPO-Ab, 0–34 mIU/l; PTH, 10–75 pg/ml).
Serum IGF1 levels were measured using a two-site
IRMA kit (Diagnostics System Laboratories, Inc., Web-
ster, TX, USA). The IGF1 intra- and inter-assay coeffi-
cients of variation (CV) were 3.4 and 8.2% respectively.
The values obtained were standardized by age and sex
and expressed in SDS. Urine iodine levels were analyzed
with an automated system (Autoanalyzer 3 system, Bran
CLuebbe GmbH, Nordestedt, Germany) (reference
range: 100–200 mg/l). The other parameters were mea-
sured by a standardized automatic colorimetric method
using the Cobas Integra 400 Analyzer (USA).Table 1 Main clinical, biochemical and bone health data
in children with SH and in controls
SH children Controls P
Age (years) 9,8 ± 3,5 10,9 ± 2,7 ns
H Z-score −0,37 ± 1,33 −0,60 ± 1,49 ns
TH Z-score −0,83 ± 0,92 −0,79 ± 0,87 ns
BMI Z-score 0,32 ± 1,23 −0,52 ± 1,2 < 0,05
EO/EC 0,93 ± 0,13 na na
TSH (IU/l) 6,39 ± 1,25 2,84 ± 0,92 < 0,0001
FT4 (ng/dl) 1,28 ± 0,13 1,27 ± 0,10 ns
IGF-1 Z-score −0,12 ± 1,39 −0,30 ± 0,91 ns
Ca (mg/dl) 9,80 ± 0,37 9,79 ± 0,29 ns
P (mg/dl) 4,90 ± 0,51 4,80 ± 0,38 ns
ALP (IU/l) 203,20 ± 75,95 209,76 ± 65,48 ns
PTH (pg/ml) 36,77 ± 12,65 41,52 ± 25,28 ns
BMD Z-score −0,4 ± 1,36 −0,2 ± 1,2 ns
Ad-SoS Z-score 0,01 ± 1 0,1 ± 1,2 ns
BTT Z-score −0,03 ± 0,8 0,04 ± 1,1 nsImaging studies
In all subjects bone status was evaluated by DXA, the
most widespread diagnostic tool to assess bone health,
and by QUS. Bone mineral density was measured by
DXA at the lumbar spine from the first to the fourth
lumbar vertebra (L1–L4), using a Hologic QDR 1000
densitometer (Hologic, Waltham, MA, USA). Daily cali-
brations of the densitometer performed with a phantom
during a 1-year period had provided a coefficient of vari-
ation of 0.56%. All examinations were carried out in the
continuous presence of trained technicians. BMD results
were expressed as g/cm2 and as BMD Z-score calculated
on the basis of the normal reference values for age and
sex provided by the DXA system manufacturer. Bone
quality was assessed in each subject by QUS measure-
ments performed with a DBM Sonic 1200 bone profiler
(Igea S.r.l., Carpi, MO, Italy) employing a sound fre-
quency of 1.25 MHz. QUS is an easy, cheap and
radiation-free technique to evaluate bone mineral status
at peripheral skeleton through amplitude-dependent
speed of sound (Ad-SoS), that expresses the ultrasound
velocity inside the bone, and bone transmission time
(BTT), reflecting the bone characteristics without the
interference of the soft tissue. QUS was performed on
the second to the fifth proximal phalanges of the non-
dominant hand and the mean value per person was cal-
culated. Measurements were performed by the same op-
erator and the coefficient of variation was 0.73%,
determined by repeated measurements in a subgroup of
12 subjects (three measurements per person on three
different days). Ad-SoS and BTT results were expressed
as Z-scores calculated on the basis of the normal values
for age and sex obtained in a large Italian population
sample [28].
In agreement with the International Society for Clin-
ical Densitometry [29], BMD was considered to benormal when values were above −2 Z-score , a similar
cut-off was used for Ad-SoS and BTT.Statistical analysis
The statistical analyses were conducted using SPSS for
Windows, version 15.0 (SPSS Inc., Chicago, IL, USA).
All data are expressed as mean ± S.D. Comparison be-
tween patients and controls for all variables was per-
formed by paired Student’s t-test or Wilcoxon matched
pairs test as appropriate. Pearson’s correlation coefficient
was used to evaluate the relationship between variables.
Multiple stepwise regression analysis was used to
evaluate the effect of age, sex, BMI, thyroid hormone
status and duration of SH on BMD, Ad-SoS and BTT.
Differences were considered statistically significant when
P <0.05.Results
Both SH and control children reported mild to moderate
physical activity. None of them were smokers. Daily cal-
cium intake resulted below the recommended intake of
1300 mg/day [30] in the majority of subjects in both
groups (820±272 mg/day vs 862±352 mg/day in SH and
controls, respectively, p=n.s.). None had any other dis-
ease or was taking any medications known to affect bone
metabolism. Clinical, biochemical and hormonal data as
well as BMD and QUS results of children with SH com-
pared with controls are reported in Table 1. Mean lumbar
BMD Z-score in SH children (−0.4 ± 1.36) and in controls
(−0.2 ± 1.2) was within the normal range, without any sig-
nificant difference within the two groups (Figure 1). Two/25
SH children (8%) showed a BMD Z-score < −2, however no
Figure 1 Bone mineral density (BMD) (A), and bone quality expressed by Ad-SoS (B) and BTT (C) Z-scores in children with subclinical
hypothyroidism compared with the control group. (The boxes show medians, 25th and 75th percentiles, and the whiskers represent the
highest and lowest values).
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remaining group of SH children was detected. Moreover,
the same percentage of children with reduced BMD was
also detected in the controls.
As for the results of QUS, mean Ad-SoS Z-score as
well as mean BTT Z-score were normal in SH children
(0.01 ± 1.0 and −0.03 ± 0.8, respectively) and not signifi-
cantly different from the controls (0.1 ± 1.2 and 0.04 ±
1.1, respectively) (Figure 1). All these parameters still
were comparable even when they were corrected for
chronological age. No difference was found in BMD,
Ad-SoS and BTT Z-scores between males and females
and between prepubertal and pubertal subjects in SH
children (data not shown). Biochemical parameters of
bone turnover, Ca, P, ALP and PTH levels, were normal
and comparable in both groups. As expected, in SH chil-
dren TSH levels were significantly higher than in con-
trols, ranging from 4.58 IU/L to 8.88 IU/L, free T4
concentration were similar and within the normal range
in both groups. BMI was significantly higher in SH chil-
dren than in controls (p = 0.02) and 2/25 SH children
were obese (BMI > 2 SDS). However, no relationship
was detected between BMI-SDS and BMD Z-score, Ad-
SoS and BTT Z-scores. A positive relationship was
detected between height and BMD Z-score as expected
(r = 0.59, p <0.02). Moreover, BMD Z-score was posi-
tively correlated with both Ad-SoS and BTT Z-scores
(r = 0.42, p <0.04 and r = 0.52, p <0.008, respectively).
After multiple regression analysis, neither TSH levels
at study entry or the duration of SH significantly
affected BMD, Ad-SoS and BTT Z-scores.Discussion
In this study we evaluated whether subclinical
hypothyroidism in children may impact on biochemical
markers of bone metabolism, and on bone structure and
quality. Compared to children with TSH within normal
range, biochemical markers of bone metabolism and
bone health, evaluated by both bone mineral density andbone quality, were not impaired in children with un-
treated long lasting idiopathic SH.
The peak bone mass is mainly reached during adoles-
cence or early adulthood and, therefore, any factor
affecting bone growth and remodeling or bone storage
during childhood might impair the attainment of an op-
timal peak bone mass, predisposing to osteoporosis and
fracture later in life.
It is well recognized that along with genetic, ethnic,
nutritional and hormonal factors as well as lifestyle and
physical activities, also thyroid hormone and TSH play
an important role in skeletal growth and bone mineral
homeostasis. Children with untreated hypothyroidism
may have delayed skeletal maturation and reduced
growth velocity leading to short stature, whereas no data
on bone health are available. However, no impairment in
bone health evaluated by DXA and QUS was observed
in congenital hypothyroid children and adolescents after
long-term L-thyroxine replacement therapy [31,32].
Conversely, in another study BMD was normal in trea-
ted children with congenital hypothyroidism but slightly
lower than healthy controls [33]. In our SH children
height was normal, within the target height, and skeletal
maturation was adequate to the chronological age. None
of them showed clinical signs or symptoms of
hypothyroidism such as goiter, fatigue, mood changes or
impaired concentration. Data on the effect of subclinical
hypothyroidism on bone mineral status in children are
completely lacking, while a few studies in adults yielded
conflicting results. In the Hunt study [34], not statisti-
cally significant differences in BMD were found if TSH
was within or above the reference range. Conversely,
Grimmes et al. in the Tromso study showed that post-
menopausal women with serum TSH above the 97.5 per-
centile had a BMD significantly higher than women with
serum TSH within the normal range [20]. This data is in
agreement with the results reported by Bertoli et al. [18]
of a mean leg BMD higher than controls in subclinical
premenopausal women. However, other studies have
shown a reduced BMD and an increased risk of fracture
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[36] evaluated the risk of hip fractures in a prospective
cohort study of 3567 adults aged 65 years or older with
subclinical thyroid dysfunction. The results of the study
showed that men with high TSH levels, but lower than
10 mIU/L, had an increased risk of fracture, thus sug-
gesting that even mild subclinical hypothyroidism may
have deleterious effects on bone. Moreover, Nagata et al.
[37] recently reported that calcaneus osteosonographic
assessment indices of right feet, measured using the
quantitative ultrasound, were lower in postmenopausal
women with SH than in controls.
To our knowledge, this is the first study exploring the
bone mineral status in children with SH. Our results in-
dicate that SH children have a normal bone density and
structure as assessed by lumbar DXA and phalangeal
QUS. Both Ad-SoS and BTT were normal and compar-
able to the controls, despite the long lasting SH. More-
over, our study indicates that phalangeal QUS is a
reliable tool to evaluate bone health, since a good correl-
ation was found with DXA, suggesting that QUS may
represent an easy and useful tool for the bone health
screening in children with SH.
Conclusion
In this study we showed that bone health assessed at
lumbar spine by DXA and at phalanges of the hand by
QUS, was not affected in long term untreated SH chil-
dren and adolescents.
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